tooyes tirzepatide Weight Loss Injections F.D.A. Approves New Obesity Drug

You can reach your doctor at any point about side effect questions, dose adjustments, or just reassurance during the adjustment period

These changes will affect Novos blockbuster weight-loss therapy Wegovy, as well as its older GLP-1 drug Saxenda, according to the FDAs announcement on Tuesday

Your brain often responds to this perceived energy emergency by sending strong chemical signals to seek out highly caloric, sweet foods

Within the next two weeks, Novo Nordisk is expected to announce the results of perhaps the most ambitious studies yet of its blockbuster GLP-1 drug semaglutide whether the medicine can help slow the progression of Alzheimers disease

Riboflavin has neuroprotective potential: focus on parkinson's disease and migraine